Head-to-head · Cost-Efficiency Index
NP2GO vs Renlo Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NP2GO
Shoppers inside its 40 served states who want both molecules disclosed and will vet the pharmacy themselves.
Visit NP2GORenlo Health
Someone who wants a flat monthly bill that will not step up, with a refund route if it does not work.
Visit Renlo HealthThe verdict
NP2GO takes it, leading the Cost-Efficiency Index 79 to 78. $150 semaglutide and $250 tirzepatide across 40 states — solid regional reach and full price disclosure, but the coverage gap and missing LegitScript verification cap the value. Renlo Health still earns a C — Someone who wants a flat monthly bill that will not step up, with a refund route if it does not work.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NP2GO.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NP2GO | Renlo Health |
|---|---|---|
| Cost-Efficiency Index | 79/100 | 78/100 |
| Semaglutide / mo | $150/mo | $199/mo, billed monthly at every dose |
| Tirzepatide / mo | $250/mo | $269/mo, billed monthly at every dose |
| Semaglutide / yr (modeled) | $1,800 | $2,388 |
| Tirzepatide / yr (modeled) | $3,000 | $3,228 |
| Coverage | AK, AZ, AR, CA, CO, CT, DE, DC, FL, HI, ID, IL, IA, KS, KY, ME, MD, MA, MI, MN, MT, NE, NV, NH, NJ, NM, NY, ND, OK, OR, PA, RI, SD, TX, UT, VT, VA, WA, WV, WY | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #35 | #42 |
NP2GO
79/100Where the value is
- Both molecules disclosed — $150 semaglutide / $250 tirzepatide — for straightforward cost modeling
- Broad 40-state footprint — wider than most non-nationwide operators
- Flat, predictable pricing
The tradeoffs
- 40 states, not all 50 — a coverage gamble that dents its access score
- Not LegitScript-certified — oversight harder to verify
Renlo Health
78/100Where the value is
- The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
- Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
- Same price at every dose with a price-lock badge, so titrating up never moves the bill
The tradeoffs
- A struck-through $299 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
- That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.